- Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss
- SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis
- Predicting chronic spontaneous urticaria symptom return after omalizumab treatment discontinuation: Exploratory analysis
- Effects of intranasal insulin on endogenous glucose production in insulin-resistant men
- Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: A systematic review
- Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: Post hoc analyses from two phase 3 trials
- Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blinded, etanercept- and placebo-controlled study (CIMPACT)
- Acute kidney injury during treatment with high-dose cloxacillin: A report of 23 cases and literature review
- Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes
- Postmarketing modifications of drug labels for cancer drugs approved by the US Food and Drug Administration between 2006 and 2016 with and without supporting randomized controlled trials
- Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapy
- Efficacy and safety of SER120 nasal spray in nocturia patients pooled analysis of 2 randomized, double-blind, placebo-controlled phase 3 trials
- Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial
- Phase II study of two weeks on, one week off sunitinib scheduling in patients with metastatic renal cell carcinoma
- Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: A meta-analysis of 25 randomized controlled trials
Feed Sources
